%1

This regulation adopts no significant risk levels for: Acrylamide, Allyl Chloride, Aniline, Azobenzene, DDVP (Dichlorvos), Folpet, Furmecyclox, Hydrazine, Hydrazine sulfate, 4,4'-Methylene bis(N,N-dimethyl)­ benzeneamine, N-Nitrosodiethanolamine, N-Nitrosomethylethylamine, Pentachlorophenol, and Hexachlorocyclohexane (alpha, beta, and gamma isomers).  

The purpose of these regulations is to provide some "safe harbor" levels and methodologies, and criteria for exposure assessment, which will assist persons in making certain that their discharges, releases or exposures pose no significant risk or would have no observable effect within the meaning of the Act. Article 7, commencing at section 12701, addresses the determination of whether exposures to carcinogens listed under the Act pose no significant risk within the meaning of the Act. Article 8, commencing at section 12801, addresses the determination of whether exposure to listed reproductive toxins would produce no observable effect within the meaning of the Act. 

This final statement of reasons sets forth the reasons for the final language adopted by the Agency for section 12201 (a) and (b) , and responds to the objections and recommendations submitted regarding those provisions. Under the amended definition of "in the course of doing business", the term would include any business activity without regard to whether it is conducted for profit.

This final statement of reasons explains the lead agency's reasons for accepting some of the objections and recommendations, while declining to follow others, for the adoption of the regulatory proposal designated R-48-87 under the Safe Drinking Water and Toxic Enforcement Act of 1986. 

This final statement of reasons sets forth the reasons for the final language adopted by the Agency for section 12902 and responds to the objections and recommendations submitted regarding that section. This regulation provides uniform definitions and establishes a process by which the lead agency can evaluate chemicals for listing pursuant to this provision of the Act. 

This final statement of reasons sets forth the reasons for the repeal of Section 12713 (Exposure to Foods, Drugs, Cosmetics, and Medical Devices) and the amendment to Section 12701 (General), and responds to the objections and recommendations submitted regarding these actions. 

This final statement of reasons sets forth the reasons for the amendment to section 12713 and responds to the objections and recommendations submitted regarding those amendments. 

This regulation adopts no significant risk levels for Benzyl chloride of 4 micrograms per day and Bromodichloromethane of 5 micrograms per day. 

This regulation will allow persons responsible for an exposure, discharge or release involving nickel and nickel compounds to determine whether such exposure, discharge or release is exempt from the Act.

This proposed regulation adopts a no significant risk level for: Aldrin, Asbestos, Carbon tetrachloride, DDT/DDE/DDD, para-Dichlorobenzene, Dieldrin, 1,4-Dioxane, N-Nitrosodipropylamine, and Urethane.